MSL
REGN icon

Mackay Shields LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Mackay Shields LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,343
Closed -$10.7M – 609
2022
Q1 		$10.7M Sell
15,343
-458
-3% -$290K 0.09% 213
2021
Q4 		$9.98M Sell
15,801
-221
-1% -$136K 0.08% 232
2021
Q3 		$9.7M Sell
16,022
-463
-3% -$287K 0.09% 218
2021
Q2 		$9.21M Sell
16,485
-10,843
-40% -$5.49M 0.09% 224
2021
Q1 		$12.9M Sell
27,328
-20,643
-43% -$10.1M 0.09% 228
2020
Q4 		$23.2M Buy
47,971
+1,276
+3% +$689K 0.16% 143
2020
Q3 		$26.1M Buy
46,695
+2,851
+7% +$1.73M 0.18% 113
2020
Q2 		$27.3M Buy
43,844
+10,010
+30% +$5.68M 0.22% 101
2020
Q1 		$16.5M Buy
33,834
+15,164
+81% +$6.25M 0.15% 161
2019
Q4 		$7.01M Sell
18,670
-2,892
-13% -$973K 0.05% 399
2019
Q3 		$5.98M Sell
21,562
-6,878
-24% -$2.04M 0.04% 447
2019
Q2 		$8.9M Sell
28,440
-10,112
-26% -$3.37M 0.06% 367
2019
Q1 		$15.8M Buy
38,552
+17,480
+83% +$7.2M 0.11% 219
2018
Q4 		$7.87M Buy
21,072
+8,713
+70% +$3.19M 0.06% 361
2018
Q3 		$4.99M Sell
12,359
-160
-1% -$60.9K 0.04% 447
2018
Q2 		$4.32M Sell
12,519
-20,050
-62% -$6.27M 0.03% 518
2018
Q1 		$11.2M Buy
+32,569
New +$11.3M 0.07% 328

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Mackay Shields LLC's REGN Position: Q2 2022 in Review

Mackay Shields LLC sold out of Regeneron Pharmaceuticals (REGN) in Q2 2022, closing a stake of 15,343 shares — an estimated $10.7M sold.

Mackay Shields LLC first reported a position in REGN in Q1 2018 and held it in 17 quarters. The position peaked at $27.3M in Q2 2020. 1,064 funds tracked by Wall St. Rank hold REGN as of Q2 2022.

  • Mackay Shields LLC reported no remaining Regeneron Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 15,343 Regeneron Pharmaceuticals shares in Q2 2022, an estimated $10.7M.
  • Mackay Shields LLC first reported a position in Regeneron Pharmaceuticals in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Regeneron Pharmaceuticals position peaked at $27.3M in Q2 2020.
  • 1,064 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.